TRACER PHARMA ApS: Financial statements 2022
CVR: 34090106
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,883,373 and a net result of DKK 145,040 compared with DKK 832,254 the year before. That is a decrease of 2.1% compared with the year before. Equity in the 2022 report amounted to DKK 1,627,005. The solvency ratio was 47.3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 3,883,373
- Profit/Loss
- DKK 145,040
- Equity
- DKK 1,627,005
- Total Assets
- DKK 3,438,896
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.9 mio. | 145 t. | 1.6 mio. | 5 |
| 2021 | - | 4 mio. | 832 t. | 1.5 mio. | 5 |
| 2020 | - | 4.4 mio. | 455 t. | 650 t. | 5 |
| 2019 | - | 3 mio. | -330 t. | 194 t. | - |
| 2018 | - | 3.3 mio. | 417 t. | 525 t. | 4 |
Official annual report
Keep an eye on TRACER PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.